Zobrazeno 1 - 10
of 302
pro vyhledávání: '"FRUSTACI S"'
Autor:
De Paoli, A. *, Chiara, S., Luppi, G., Friso, M.L., Beretta, G.D., Del Prete, S., Pasetto, L., Santantonio, M., Sarti, E., Mantello, G., Innocente, R., Frustaci, S., Corvò, R., Rosso, R.
Publikováno v:
In Annals of Oncology February 2006 17(2):246-251
Autor:
Stefanovski, P.D., Bidoli, E., De Paoli, A., Buonadonna, A., Boz, G., Libra, M., Morassut, S., Rossi, C., Carbone, A., Frustaci, S.
Publikováno v:
In European Journal of Surgical Oncology March 2002 28(2):153-164
Autor:
BIASCO, GUIDO, ASTORINO, MARIA, DI BATTISTA, MONICA, PANTALEO, MARIA ABBONDANZA, SAPONARA, MARISTELLA, Velo D, Angriman I, Baldan A, Baseggio M, Basso U, Battaglia G, Bertin M, Bertorelle R, Bocus P, Brosolo P, Bulzacchi A, Cannizzaro R, Da Dalt GF, Errante D, Fedrigo M, Frustaci S, Lionetti I, Massani M, Mencarelli R, Montesco MC, Norberto L, Pasquali C, Pastorelli D, Rossi CR, Ruffolo C, Salvagno L, Vittadello F, Zaccaria F, Zovato S, Farinati F, on behalf of The Section of Oncology of the Italian Society of Gastroenterology, Interdisciplinary GIST Group G. I. GIST, GIST Study Group
Publikováno v:
European Journal of Cancer Prevention. 18:106-116
Gastrointestinal stromal tumors (GISTs), tumors characterized by c-KIT mutations, are the most frequent mesenchymal tumors of the digestive tract. The stomach is the most commonly involved site. Localization, size and mitotic rate are reliable predic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a92e7828fc7186c8356bd6c3a6eab22b
https://doi.org/10.1097/cej.0b013e32830c8da8
https://doi.org/10.1097/cej.0b013e32830c8da8
Autor:
Favaretto, A. *, Ceresoli, G.L., Paccagnella, A., Barbieri, F., Bearz, A., Ghiotto, C., Oniga, F., Schiavon, S., Frustaci, S., Villa, E.
Publikováno v:
In Annals of Oncology November 2000 11(11):1421-1426
Autor:
D'Angelo, S, Lorusso, V, Piras, MR, Sansonno, D, Benedetti, A, Montesarchio, V, Attili, AF, Frustaci, S, Barni, S, Pirisi, M, Carpani, D, Magini, G, Daniele, B., GIANNITRAPANI, Lydia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::0d88d22a06b9a9a7ccbee5e0d385f3ba
http://hdl.handle.net/10447/132552
http://hdl.handle.net/10447/132552
Autor:
Lorusso, V, Germano, D, Zolfino, MT, Sansonno, D, Benedetti, A, Montesarchio, V, Attili, AF, Frustaci, S, Gasbarrini, A, Cillo, U, Carpani, D. Picciotto A, D’Angelo S., MONTALTO, Giuseppe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3658::ff4cc8721f67d0e5335c6728b21625e9
http://hdl.handle.net/10447/96705
http://hdl.handle.net/10447/96705
Autor:
BAJETTA E, DI BARTOLOMEO M, MARIANI L, CASSATA A, ARTALE S, FRUSTACI S, PINOTTI G, BONETTI A, CARRECA I, BONAGLIA L, MARINI G, IANNELLI A, CORTINOVIS D, FERRARIO E, BERETTA E, LAMBIASE A, BUZZONI R, ITALIAN TRIALS IN MEDICAL ONCOLOGY I. T. M. O. GROUP, BIASCO, GUIDO
BACKGROUND The aim of the current randomized Phase II study was to investigate the efficacy and safety of capecitabine combined with irinotecan as first-line treatment in metastatic colorectal carcinoma (CRC). METHODS A total of 140 patients received
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eda0b6d1df3e80c1c98f52f3ade294e
http://hdl.handle.net/10447/16091
http://hdl.handle.net/10447/16091
Autor:
Di Bartolomeo, M., Rosato, G., Banzi, M., Pella, N., Zampino, M.G., Rimassa, L., Maiello, E., Marchetti, P., Lonardi, S., Labianca, R., Zaniboni, A., Sobrero, A., Ferrari, D., Bidoli, P., Iaffaioli, V., De Placido, S., Frassineti, L., Frustaci, S., Nicolini, M., Vernieri, C., Galli, F.
Publikováno v:
In Annals of Oncology October 2017 28 Supplement 6:vi9-vi9
Autor:
Barone, C., Boni, C., Ciardiello, F., Cognetti, F., Colucci, G., Di Costanzo, F., Alfredo Falcone, Ferra, F., Frustaci, S., La Bianca, R., Sobrero, A.
Publikováno v:
Università di Pisa-IRIS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d1458e8a707d193d70ca2c930d6aea7d
http://hdl.handle.net/11568/112763
http://hdl.handle.net/11568/112763